Expert Point of View - Adenosine Deaminase (ADA) in Peritoneal Tuberculosis - Tahiri Joutei Hassani Mohammed - Hliwa Wafaa - Badre Wafaa

ewgn-vol22-issue2-FINAL

WORLD GASTROENTEROLOGY NEWS Official e-newsletter of the World Gastroenterology Organisation VOL. 22, ISSUE 2 OCTOBER 2017 In this issue www.worldgastroenterology.org WGO Guidelines Program: An Interview with Professor Guido Tytgat WDHD: Inflammatory Bowel Disease – Challenges and Hopes in Szczecin, Poland Wojciech Marlicz, MD, PhD, FACG Adenosine Deaminase (ADA) in Peritoneal Tuberculosis Tahiri Joutei Hassani Mohammed Associate professor of gastroenterology Medicine School of Casablanca – Hassan II University Summary Tuberculosis (TB) is a global public health issue. Peritoneal tuberculosis (PT) is the most common form of abdominal tuberculosis and leading cause of ascites in devel-oping countries. PT has become a real concern in all countries because of the HIV epidemic. Peritoneal tuberculosis is more often seen in patients with advanced renal or liver disease. Although it is an invasive procedure, laparoscopy is still considered to be the gold standard for PT diagnosis. The diagnosis of peritoneal tuberculosis remains a real challenge because of the lack of non-invasive and reliable diagnostic tests. Nowa-days, ascitic adenosine deaminase can be a good, non-invasive test for PT diagnosis. Introduction Tuberculosis (TB) is a global pandemic caused by Mycobacterium tuberculosis. Tuber-culosis can involve all tissues and organs with a large spectrum. Most TB localizations are pulmonary; however, extrapulmonary tuberculosis accounts for about 20 % of total cases 1. Extrapulmonary TB has increased worldwide due to many factors such as the Continued on page 4 Hliwa Wafaa Professor of Gastroenterology Medicine School of Casablanca – Hassan II University Badre Wafaa Professor of Gastroenterology Medicine School of Casablanca – Hassan II University


ewgn-vol22-issue2-FINAL
To see the actual publication please follow the link above